SenoGuard Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Crowdfunding
- (Announced)
- Latest Deal Amount
-
$56.4K
- Investors
-
2
SenoGuard General Information
Description
Developer of radiation-free cancer treatment designed to treat patients suffering from breast cancer. The company has developed a new form of accommodative balloon cryoablation that provides recurrence protection with minimal to no side effects and at a fraction of the cost, enabling doctors to avoid problems associated with radiation therapy including multiple visits, possible cardiovascular complications, and cosmetic disfigurement.
Contact Information
Website
www.senoguard.comCorporate Office
- 221 Main Street Box 351
- Seal Beach, CA 90740
- United States
Corporate Office
- 221 Main Street Box 351
- Seal Beach, CA 90740
- United States
SenoGuard Timeline
SenoGuard Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Equity Crowdfunding | 31-Mar-2025 | $56.4K | Announced | Generating Revenue | ||
| 3. Accelerator/Incubator | 12-Dec-2025 | Completed | Generating Revenue | |||
| 2. Grant | 01-Dec-2024 | $1000K | Completed | Generating Revenue | ||
| 1. Grant | 15-Jan-2023 | $256K | Completed | Generating Revenue |
SenoGuard Patents
SenoGuard Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240148424-A1 | Apparatus and method for marginal ablation in tissue cavity | Pending | 26-Feb-2021 | ||
| WO-2022183117-A1 | Apparatus and method for marginal ablation in tissue cavity | Inactive | 26-Feb-2021 | ||
| US-20260263136-A1 | Cryoablation system and method for treating breast tumor excision cavity margins with adaptive contact, tissue compression, and controlled cryogenic temperature delivery | Pending | 26-Feb-2021 | ||
| US-20210153920-A1 | Apparatus and method for ablation of soft tissue surrounding a breast cavity following lumpectomy | Inactive | 22-Nov-2019 | A61B18/02 |
SenoGuard Signals
SenoGuard Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Octane (California) | Accelerator/Incubator | |||
| US National Science Foundation | Accelerator/Incubator |
SenoGuard FAQs
-
When was SenoGuard founded?
SenoGuard was founded in 2019.
-
Where is SenoGuard headquartered?
SenoGuard is headquartered in Seal Beach, CA.
-
What is the size of SenoGuard?
SenoGuard has 4 total employees.
-
What industry is SenoGuard in?
SenoGuard’s primary industry is Biotechnology.
-
Is SenoGuard a private or public company?
SenoGuard is a Private company.
-
What is SenoGuard’s current revenue?
The current revenue for SenoGuard is .
-
Who are SenoGuard’s investors?
Octane (California) and US National Science Foundation have invested in SenoGuard.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process